CageSaulJohnsonMD

PubMed

• American Society of Hematology: building a comprehensive minority recruitment and retention professional program.
  Margo R Rollins, Rahma M Warsame, Melody Smith, Arturo Molina, Rayne H Rouce
  Blood Advances. 2024-12-24
• 12 citations
  Proteasome Inhibition Induces Both Antioxidant and Hb F Responses in Sickle Cell Disease Via the Nrf2 Pathway
  Vinod Pullarkat, Zhuo Meng, Stanley M. Tahara, Cage S. Johnson, Vijay K. Kalra
  Hemoglobin. 2014-05-14
• 221 citations
  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.
  Elliott Vichinsky, Lynne Neumayr, Jeffrey I. Gold, Michael W. Weiner, Randall R. Rule
  JAMA. 2010-05-12

Journal Articles

• Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Anemia  
  Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, EgglestonB, Kesle rK, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar..., JAMA, 1/1/2010
• Definitions of the phenotypic manifestations of sickle cell disease  
  Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, Johnson CS, Rogers ZR, Smith-Whitley K, Wang WC, Telen MJ, on Behalf of the Investigators at the Compr..., American Journal of Hematology, 1/1/2010
• A novel high-throughput screening assay for sickle cell disease drug discovery  
  Pais E, Cambridge JS, Johnson CS, Meiselman HJ, Fisher TC, Alexy T, Journal of Biomolecular Screening, 1/1/2009
• Sickle cell disease summit: From clinical and research disparity to action  
  Hassell K, Pace B, Wang W, Kulkarni R, Luban N, Johnson CS, Eckman J, Lane P, Woods WG, American Journal of. Hematology, 1/1/2009
• Development and validation of SIMS: An instrument for measuring quality of life of adults with sickle cell disease  
  Adams-Graves P, Lamar K, Johnson C, Corley P, Am J Hematol, 1/1/2008
• Rheological behavior of sickle and normal red blood cell mixtures in sickle plasma: Implications for transfusion therapy  
  Alexy T, Pais E, Armstrong JK, Wenby RB, Meiselman HJ, Johnson CS, Fisher TC, Transfusion, 1/1/2006
• A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells  
  Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK, Journal of Immunology, 1/1/2006
• Bone Marrow Embolism in Sickle Cell Disease: A Review  
  Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ, American Journal of Hematology, 1/1/2005
• Myocardial injury or infarction associated with fat embolism in sickle cell disease: A report of three cases with survival  
  Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ, American Journal of Hematology, 1/1/2005
• Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients  
  Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C, Medicine, 1/1/2005
• L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells  
  Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR, BMC Blood Disorders, 1/1/2005
• Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor  
  Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK, Blood, 1/1/2003
• Outcome in hemoglobin SC disease: A four–decade observational study of clinical, hematologic, and genetic factors  
  Powars DR, Hiti A, Ramicone E, Johnson C, Chan L, American Journal of Hematology, 1/1/2002
• Renal complications of the sickle cell diseases  
  Johnson C, Hematology, 1/1/1999
• Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cel...  
  Sultana C, Shen Y, Johnson C, Kalra VK, Journal of Cellular Physiology, 1/1/1999
• Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to trans endothelial mi...  
  Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK, Blood, 1/1/1998
• Pulmonary complications raise risks in sickle cell disease  
  Weil J, Thomas A, Castro O, Johnson CS, Pulmonary Reviews, 1/1/1998
• The sickle cell delayed hemolytic reaction syndrome  
  Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM, Transfusion, 1/1/1997
• Platelet activating factor in sickle cell hemoglobinopathy  
  Ibe BO, Shin OO, Johnson C, Kurantsin-Mills J, Raj JU, Journal of Laboratory and Clinical Medicine, 1/1/1997
• The sickle cell hemolytic transfusion reaction syndrome  
  Petz LD, Calhoun L, Shulman I, Johnson CS, Herron CM, Transfusion, 1/1/1997
• Myocardial infarction in sickle cell disease  
  Martin CR, Johnson CS, Cobb C, Tatter D, Haywwood LJ, Journal of the National Medical Association, 1/1/1996
• Blood transfusions and immunophenotypic alterations and lymphocyte subsets in sickle cell anemia  
  Wong WY, Powars DR, Operskalski EA, Hassett J, Parker JW, Sarnaik S, Pegelow CH, Hilgartner MW, Johnson CS, Zhou Y, Ku P, Mosley JW, and the Transfusion Safety Study G..., Blood, 1/1/1995
• Infectious disease testing for blood transfusions  
  JAMA, 1/1/1995
• Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia  
  Powars DR, Meiselman HJ, Fisher TC, Hiti A, Johnson C, American Journal of Pediatric Hematology/Oncology, 1/1/1994
• Multisystem damage associated with tricorporeal priapism in sickle cell disease  
  Sharpsteen JR, Powars D, Johnson C, Rogers ZR, Williams WD, Posch RJ, American Journal of Medicine, 1/1/1993
• Join now to see all

Books/Book Chapters

• Synopsis of Hematology: Including blood diseases in the tropics 
  Editors: I Okpala, C Johnson.CreateSpace, Charleston, SC2010
• Encyclopedia of Public Health 
  Chapter: Sickle Cell Disease 
  Page 6 - 15Johnson CSEditors: Heggenhougen K, Quah S.Academic Press, San Diego2008
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: The acute chest syndrome 
  Page 857 - 879Johnson CSW.B. Saunders Company, Philadelphia2005
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: Arterial blood pressure and hyperviscosity in sickle cell disease 
  Page 827 - 837Johnson CSW.B. Saunders Company, Philadelphia2005
• Tropical Lung Disease 
  Chapter: Johnson CS 
  Page 475 - 505Johnson CSEditors: Sharma OP.Taylor & Francis, New York2005
• Practical Management of Haemoglobinopathies 
  Chapter: The Liver in Sickle Cell Disease 
  Johnson CSEditors: Okpala IE.Blackwell Publishing Ltd.2004
• The Management of Sickle Cell Disease 
  Chapter: Gallbladder and Liver 
  Johnson CSNIH PublicationEdition 4th ,2002
• Medical, Psychosocial and Vocational Aspects of Disability 
  Chapter: Johnson CS 
  Johnson CSEditors: Brodwin MG, Tellez F, Brodwin SK.Elliott & Fitzpatrick, Inc.Edition 2nd ,2002
• Interactions of Blood and Pulmonary Circulation 
  Chapter: Mechanisms of monocyte migration following sickle erythrocyte adherence to endothelium 
  Kalra VK, Selvaraj S, Johnson CSEditors: Weir EK, Reeve HL, Reeves JT.Futura Publishing Company, Armonk, NY2002
• Vascular Protection 
  Chapter: Sickle erythrocyte interaction with endothelial cells causes endothelial dysfunction 
  Kalra VK, Johnson CSEditors: Rubanyi G, Dzau V, Cooke J.Harwood Academic Publishers2000
• Sickle Cell disease, Hematology/Oncology Clinics of North America 
  Chapter: Priapsim 
  Powars DR, Johnson CSEditors: Charache S, Johnson CS.W.B. Saunders Company, Philadelphia1996
• Hematology/Oncology Clinics of North America 
  Chapter: Sickle Cell disease 
  Editors: Charache S, Johnson CS.W.B. Saunders Company, Philadelphia1996
• Managment and Therapy of Sickle Cell Disease 
  Editors: Reid CD, Charache S, Lubin B, Johnson C, Ohene-Frempong K.NIH PublicationEdition 3rd ,1995
• Conn's Current Therapy 
  Chapter: Sickle Cell Disease 
  Johnson CSEditors: Rakel R.W.B. Saunders Company1993
• Medical, Psychosocial and Vocational Aspects of Disability 
  Chapter: Medical, Psychosocial and Vocational Aspects of Disability 
  Johnson CS, Francis, Jr. RBEditors: Brodwin MG, Tellez F, Brodwin SK.Elliott & Fitzpatrick, Inc.1992
• Blood rheology and hyperviscosity syndromes 
  Chapter: Rheology of the sickle cell disorders 
  Page 747 - 775Stuart J, Johnson CSEditors: GDO Rowe.Balliere's Clinical Haematology1987
• Lessons for Animal Diabetes 
  Chapter: Effect of thymus transplantation on the spontaneous diabetic syndrome in athymic nude mice 
  Zeidler A, Kumar D, Johnson C, Parker JEditors: Shafir E, Renold AE.John Libbey1984
• Handbook of Severe Disability 
  Chapter: Sickle cell disease 
  Johnson CSEditors: Stolov WC, Clovers MR.U.S. Government Printing Office1981
• Red Cell Rheology 
  Chapter: Human red cell protein kinase in normal subjects and patients with hereditary spherocytosis, sickle cell disease, and autoimmune hemolytic anemia 
  Beutler E, Guinto E, Johnson CEditors: Bessis M, Shohet SB, Mohandas N.Springer - Verlag1978
• Join now to see all

Abstracts/Posters

• Rajagopal V, Kim KS, Gonsalves C, Madigan C, Johnson CS, Malik P, and Kalra VK
  Rajagopal V, Kim KS, Gonsalves C, Madigan C, Johnson CS, Malik P, and Kalra VK, Plenary Session, 28th Annual Meeting of the National Sickle Cell Disease Program, 4/9/2005
• Mechanism of PlGF mediated monocyte activation and its inhibition by curcumin in sickle cell disease
  Kalra VK, Rajagopal V, Kim KS, Perelman N, Madigan C, Johnson CS, and Malik P, 28th Annual Meeting of the National Sickle Cell Disease Program, 4/9/2005
• Hydroxyurea induced exression of erythrocyte anion exchange protein (AE1) and gamma globin in cultured erythroid progenitor cells
  Green GA, Braden BR, Mba O, Chivira SA, Ramezani L, Johnson CS, Blood, 1/1/2005
• Quality of Life and Sickle Cell Disease
  Adams-Graves, P, Johnson, C, Corley, P, Lamar, K., Blood, 1/1/2005
• Polymer-Coated RBC for In Vivo Microcirculatory Studies of RBC Aggregation: Enhanced Aggregation in Native Plasma
  Meiselman, H.J; Armstrong, J.K.; Kim, S., Johnson, P.C., FASEB J, 1/1/2005
• Fisher TC, Hiti AL, Kurtzman T, Zeng L, Meiselman HJ, Johnson CS, Coates TD, Malik P
  Fisher TC, Hiti AL, Kurtzman T, Zeng L, Meiselman HJ, Johnson CS, Coates TD, Malik P, 27th Annual Meeting of the National Sickle Cell Disease Program, 4/18/2004
• Tendinitis/Bursitis syndrome in patients with sickle cell disease
  Montgomery C, Corley PL, Johnson CS, 27th Annual Meeting of the National Sickle Cell Disease Program, 4/18/2004
• Induction of erythrocyte anion exchange [AE1] protein expression by hydroxyurea
  Green GY, Johnson CS, Blood, 1/1/2000
• Oral L-glutamine therapy reduces adherence of sickle red blood cells to human umbilical vein endothelial cells
  Niihara Y, Matsui NM, Sunga MA, Magpayo J, Embury SH, Tanaka KR, Johnson CS, Blood, 1/1/2000
• Deformability and superoxide radical production of fractionated erythrocytes in sickle cell disease
  Novak, Z., van der Waart, F., Fisher, T.C., Johnson, C.S.,Pinter, S., Meiselman, H.J., Pediatric Research, 1/1/1995
• Sickle erythrocytes exhibit increased rheologic sensitivity to oxidative damage
  Novak Z, Fisher TC, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Polymorphonuclear leucocyte deformability, f-actin content and CD 16 expression are abnormal in sickle cell disease and correlate with severity
  Fisher TC, Coates TD, Pecsvardy Z, Fabok A, Deemer K, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• SS RBC rheologic heterogeneity correlates with density and disease severity
  van der Waart FJM, Fisher TC, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Poloxamer 188 (RheothRx injection) reduces RBC aggregation in blood from patients with acute myocardial infarction
  Toth K, Haywood LJ, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Immunophenotypic alterations of lymphocyte subsets in sickle cell anemia (SCA)
  Wong WY, Powars DR, and the Transfusion Safety Study Group (TSS), Blood, 1/1/1993
• Hemorheological correlates of beta-gene haplotypes in sickle cell anemia
  Wenby RB, Fisher TC, Hiti AL, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1993
• Heterogeneity of sickle RBC deformability evaluated by a new micropore filtration method
  van der Waart FJM, Fisher TC, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Increased rheologic sensitivity of sickle erythrocytes to oxidative damage
  Novak Z, Fisher TC, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Neutrophil deformability and FcRIII expression correlate with clinical severity (beta globin haplotype) in sickle cell disease
  Coates TD, Fisher TC, Pecsvardy Z, Fabok A, Deemer K, Hiti AL, Johnson CS, Meiselman HJ, Blood, 1/1/1992
• Hemorheological effects of nonionic copolymer surfactants
  Carter C, Cooke BM, Fisher TC, Hamai H, Johnson CS, Kalra VK, Meiselman HJ, Nash GB, Sowemimo-Coker SO, Stuart J, Toth K, Wenby RB, Clinical Hemorheology, 1/1/1991
• Neutrophils have increased surface expression of adhesion receptors and decreased deformability in sickle cell disease
  Coates TD, Fisher TC, Pecsvardy Z, Fabok A, Coblentz JG, Johnson CS, Meiselman HJ, Blood, 1/1/1991
• Effects of cellular factors on the aggregation behavior of sickle (HbSS) erythrocytes
  Sowemimo-Coker SO, Johnson CS, Meiselman HJ, Clinical Hemorheology, 1/1/1991
• The in vitro effect of poloxamer 188 (RheothRx) on red blood cell aggregation in patients with acute myocardial infarction
  Toth K, Wenby RB, Haywood LJ, Johnson C, Meiselman HJ, Perfusion, 1/1/1991
• Erythropoietin (EPO) response in patients with various stages of HIV infection and anemia
  Rarick MU, Espina B, Sonka S, Johnson C, Levine A, Blood, 1/1/1990
• Aggregation behavior of density separated SS rbc
  Sowemimo-Coker SO, Lockhart JC, Johnson CS, Meiselman HJ, Blood, 1/1/1990
• Join now to see all

Lectures

• Health Maintenance for Adults with Sickle Cell Disease 
  New York Methodist Hospital, Brooklyn, NY - 5/2/2008
• Hypercoaguability in Sickle Cell Disease-Perception or Reality 
  University of South Alabama, Mobile, AL - 4/19/2008
• Sickle cell disease, Meet-the-Professor 
  San Diego, CA, 2003; San Diego, CA, 2004; Orlando, FL, 2006 - 12/9/2006
• Blood pressure and cardiac function in sickle cell disease 
  King's College London, St. Thomas' Hospital Campus, London, UK - 10/11/2004
• Hepato-biliary complications of the sickling Disorders 
  King's College London, St. Thomas' Hospital Campus, London, UK - 10/2/2000
• Renal complications of the sickle cell diseases 
  New Orleans, L - 12/4/1999
• Sickle cell disease 
  NHLBI, NIH Mini-Medical School, Washington, DC - 6/18/1998
• Pulmonary hypertension in sickle cell disease 
  Chicago, IL - 4/28/1998
• Rheology of the sickling disorders and its impact on blood pressure 
  Meharry Medical College, Nashville, TN - 4/17/1997
• Rheology of the sickling disorders 
  Duke University, Durham, NC - 4/3/1997
• Pulmonary complications of sickle cell disease 
  1/1/1988
• Join now to see all

Other

• Hydroxyurea treatment for sickle cell disease 
  
  1/1/2008
• Cerebral Infarction in the Sickle Cell Diseases: Current Concepts and Therapeutic Guidelines 
  Johnson CS
  http://www.medscape.com/viewarticle/496546
  12/30/2004
• Modulation of Fetal Hemoglobin in Sickle Cell Anemia 
  Johnson CS
  http://www.medscape.com/viewarticle/466371
  12/30/2003
• Gall Bladder and Liver Disorders in Sickle Cell Disease: a Critical Review 
  Johnson CS
  http://sickle.bwh.harvard.edu/liver.html
  1/1/2001
• Infectious disease testing for blood transfusions 
  
  1/1/1995
• Sickle cell disease: the acute chest syndrome 
  Johnson, CS
  http://sickle.bwh.harvard.edu/acutechest.html
  1/1/1995
• Acute myocardial infarction in sickle cell anemia 
  Martin C, Cobb C, Tatter D, Johnson C, Haywood LJ
  1/1/1984
• Join now to see all